Table of Contents
1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 7
2
Company Snapshot 8
2.1 Key Information 8
2.2 Company Overview 8
3
Business Description 9
3.1 Business Overview 9
3.2 Major Products and
Services 9
3.2.1 Overview 9
4 History 11
5 Competitors 12
6
Key Employees 13
7 Key Employee Biographies 14
8 Company Statement
17
9 Locations And Subsidiaries 19
9.1 Head Office 19
9.2 Other
Locations & Subsidiaries 19
10 Recent Developments 20
10.1 Financial
Announcements 20
10.1.1 Nov 14, 2007: Cyberkinetics Declares Q3 2007
Results 20
10.1.2 Aug 09, 2007: Cyberkinetics Reports Q2 2007 Results
21
10.1.3 May 10, 2007: Cyberkinetics Reports Q1 2007 Results 21
10.1.4 Dec 31, 2006: Cyberkinetics Reports Q4 2006 Results 22
10.1.5 Nov
08, 2006: Cyberkinetics Reports Q3 2006 Results 23
10.2 Corporate
Communications 23
10.2.1 Sep 19, 2006: Cyberkinetics Appoints New CFO
23
10.3 Product News 23
10.3.1 Mar 03, 2008: Cyberkinetics Andara OFS
Therapy Featured In Presentations at the AANS/CNS Meeting 23
10.3.2 Dec
11, 2007: Cyberkinetics Receives FDA Response Letter On Andara OFS System For
Acute Spinal Cord Injury 24
10.3.3 Apr 11, 2007: United States Patent And
Trademark Office Issues Cyberkinetics Patent For Andara OFS Therapy 24
10.3.4 Feb 20, 2007: Cyberkinetics Files To Market Andara OFS Therapy For
Acute Spinal Cord Injury Under Humanitarian Device Exemption 24
11
Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products 25
11.1
Cyberkinetics Neurotechnology Systems, Inc. Product Pipeline Analysis 25
11.1.1 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By
Equipment Type 25
11.1.2 Cyberkinetics Neurotechnology Systems, Inc.
Pipeline Products By Development Stage 26
11.1.3 Cyberkinetics
Neurotechnology Systems, Inc. Pipeline Products By Therapy Area 27
11.1.4
Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Clinical
Trials 27
11.1.5 Cyberkinetics Neurotechnology Systems, Inc. Pipeline
Products By News Summary 28
11.2 Andara Oscillating Field Stimulator
system 28
11.2.1 Product Description 29
11.2.2 Product Status 29
11.2.3 Clinical Trials 29
11.2.4 Product Milestone 29
11.3 Andara OFS
Plus 30
11.3.1 Product Description 30
11.3.2 Product Status 30
11.4 BrainGate Neural Interface System 31
11.4.1 Product Description
31
11.4.2 Product Status 31
11.4.3 Clinical Trials 31
12 Appendix
33
12.1 Methodology 33
12.1.1 Coverage 33
12.1.2 Secondary
Research 34
12.1.3 Primary Research 34
12.1.4 Expert Panel Validation
35
12.2 Contact Us 35
12.3 About Global Markets Direct 35
12.4
Disclaimer 35
1.1 List of Tables
Table 1: Cyberkinetics
Neurotechnology Systems, Inc.,Key Facts 8
Table 2: Cyberkinetics
Neurotechnology Systems, Inc., Key Employees, 13
Table 3:
Cyberkinetics Neurotechnology Systems, Inc., Other Locations 19
Table 4:
Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products by Equipment
Type 25
Table 5: Cyberkinetics Neurotechnology Systems, Inc. Pipeline
Products By Development Stage 26
Table 6: Cyberkinetics
Neurotechnology Systems, Inc. Pipeline Products By Therapy Area 27
Table
7: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By
Clinical Trials 27
Table 8: Cyberkinetics Neurotechnology Systems,
Inc. Pipeline Products By News Summaries 28
1.2 List of Figures
Figure 1: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products
By Development Stage 26
Figure 2: Cyberkinetics Neurotechnology
Systems, Inc. Pipeline Products By News Summary 28
Figure 3: Global
Markets Direct Methodology 33
View Cart
